Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation

(2014) KL Cooper et al.   HEALTH TECHNOLOGY ASSESSMENT

The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes

(2013) Ju Won Seok et al.   ANNALS OF NUCLEAR MEDICINE

Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes

(2013) M. van der Heiden-van der Loo et al.   ANNALS OF ONCOLOGY

Positive versus negative sentinel nodes in early breast cancer patients: Axillary or loco-regional relapse and survival. A study spanning 2000–2012

(2013) A. García Fernández et al.   BREAST

The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and18F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer

(2013) Seung Ook Hwang et al.   Journal of Breast Cancer

Comparison of the Diagnostic Value of FDG-PET/CT and Axillary Ultrasound for the Detection of Lymph Node Metastases in Breast Cancer Patients

(2012) Carolin Riegger et al.   ACTA RADIOLOGICA

Advanced Imaging Modalities in Early Stage Breast Cancer: Preoperative Use in the United States Medicare Population

(2012) Margaret L. Crivello et al.   ANNALS OF SURGICAL ONCOLOGY

Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study

(2012) Kathleen I. Pritchard et al.   JOURNAL OF CLINICAL ONCOLOGY

18F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging

(2012) D. Groheux et al.   JOURNAL OF NUCLEAR MEDICINE

Defining the Role of PET-CT in Staging Early Breast Cancer

(2012) A. M. Groves et al.   ONCOLOGIST

Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma

(2012) Bo Choi et al.   World Journal of Surgical Oncology

Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?

(2011) Bernd Gerber et al.   BREAST CANCER RESEARCH AND TREATMENT

The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan

(2011) Z. Garami et al.   EJSO

Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging

(2010) Till-Alexander Heusner et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience

(2009) Jeryong Kim et al.   WORLD JOURNAL OF SURGERY

Impact of Breast MRI on Surgical Treatment, Axillary Approach, and Systemic Therapy for Breast Cancer

(2008) Claudia S. Mameri et al.   Breast Journal